IR Information
| No. | Title | Writer | Date |
|---|---|---|---|
| 2 | Business Update: Halozyme’s Lawsuit Against MSD and Our Response | Alteogen | 2025-04-25 |
| 1 | Business Update: MSD shows Keytruda SC non-inferiority to IV, using Alteogen's ALT-B4 | Alteogen | 2025-03-29 |
Contact Investor Relations
+82-42-384-8777
ir@alteogen.com